The Role of Insulin Resistance in Cardiorenal Metabolic Syndrome
Cardiorenal metabolic syndrome (CRMS) is a health disorder arising from pathophysiological interactions among cardiovascular diseases, chronic kidney disease, diabetes, and obesity, posing a significant challenge to global healthcare systems. Insulin resistance plays a central role in the pathogenesis of CRMS. This review comprehensively explores the role of insulin resistance in CRMS, elucidating its associations with component diseases and underlying mechanisms, and aims to provide theoretical foundations for clinical management and early intervention strategies.
Authors
- Yihan Weng
- Wen Song (ORCID: https://orcid.org/0000-0001-8225-5370)
- Huimin Yu (ORCID: https://orcid.org/0000-0001-5085-3958)
- Xiang He (ORCID: https://orcid.org/0009-0008-9418-1469)
- Yusi Huang
- Jiquan Xiao
Institutions
- Shantou University (CN)
- Shantou University Medical College (CN)
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
- Southern Medical University (CN)
- South China University of Technology (CN)
Publication Details
- Journal
- Cardiology in Review
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1097/crd.0000000000001048
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29